Scalp inflammation and hair loss are closely linked conditions that affect many people in the UK, often causing significant distress. Whether driven by seborrhoeic dermatitis, psoriasis, alopecia areata, or a fungal infection such as tinea capitis, understanding the underlying cause is the essential first step towards effective treatment. This article explains the most common causes, how inflammation disrupts hair follicle function, how these conditions are diagnosed within the NHS, and what treatment and self-care options are available — including when to seek prompt medical advice.
Summary: Scalp inflammation and hair loss are commonly caused by conditions such as seborrhoeic dermatitis, psoriasis, alopecia areata, and tinea capitis, each requiring a different treatment approach.
- Scalp inflammation disrupts the hair follicle growth cycle, potentially triggering telogen effluvium (diffuse shedding) or, in scarring alopecias, permanent follicular destruction.
- Alopecia areata is an immune-mediated condition in which CD8+ T lymphocytes attack hair follicles; follicles are not permanently destroyed in most cases, so regrowth is possible.
- Scarring alopecias such as lichen planopilaris require urgent specialist assessment, as irreversible follicular damage can occur rapidly without treatment.
- NHS treatment options range from medicated shampoos and topical corticosteroids to systemic antifungals and, for severe alopecia areata, MHRA-approved JAK inhibitors (baricitinib, ritlecitinib) subject to NICE appraisal.
- High-dose biotin supplementation is not routinely recommended and can interfere with laboratory tests including thyroid function and troponin assays, per MHRA guidance.
- Prompt GP referral is advised for rapidly progressing or patchy hair loss, suspected scarring alopecia, scalp pustules or crusting, or symptoms suggesting an underlying systemic condition.
Table of Contents
- Common Causes of Scalp Inflammation and Hair Loss
- How Scalp Conditions Lead to Hair Thinning and Shedding
- Diagnosing Inflammatory Scalp Conditions in the UK
- Treatment Options Available on the NHS
- Managing Scalp Health and Supporting Hair Regrowth
- When to See a GP or Dermatologist
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Common Causes of Scalp Inflammation and Hair Loss
The most common causes include seborrhoeic dermatitis, scalp psoriasis, alopecia areata, and tinea capitis, alongside rarer scarring alopecias; identifying the precise cause is essential as treatments differ considerably.
Scalp inflammation and hair loss frequently occur together, and understanding the underlying cause is essential for effective management. Several dermatological conditions can trigger both symptoms simultaneously, ranging from immune-mediated disorders to fungal infections.
Not sure if this is normal? Chat with one of our pharmacists →
The most frequently encountered causes include:
-
Seborrhoeic dermatitis – a chronic inflammatory condition driven by an overgrowth of Malassezia yeast on the scalp, causing redness, flaking, and itching
-
Psoriasis – an immune-mediated inflammatory condition with genetic and environmental components, producing thick, scaly plaques on the scalp that can disrupt the hair follicle environment
-
Alopecia areata – an immune-mediated condition in which the body's own immune cells attack hair follicles, causing patchy or diffuse hair loss
-
Tinea capitis – a fungal infection of the scalp more common in children, which can cause inflamed, scaly patches and associated hair breakage
-
Lichen planopilaris – a rare but serious scarring (cicatricial) alopecia associated with follicular inflammation
-
Discoid lupus erythematosus, folliculitis decalvans, and dissecting cellulitis (perifolliculitis capitis abscedens et suffodiens) – further causes of scarring alopecia that require early specialist assessment to prevent irreversible follicular damage
Telogen effluvium — diffuse shedding triggered by systemic stressors such as postpartum hormonal change, febrile illness, major surgery, or certain medications — is also a common primary cause of hair loss and should be considered in the clinical assessment.
Contact dermatitis, triggered by hair dyes, shampoos, or styling products containing allergens such as paraphenylenediamine (PPD), is another important and often overlooked cause. Hormonal changes and nutritional deficiencies (particularly iron) can contribute to scalp sensitivity and hair shedding, though these typically act as aggravating rather than primary factors. The role of vitamin D deficiency in hair loss is less well established, and testing and treatment should be guided by clinical indication rather than routine supplementation. Identifying the precise cause requires a thorough clinical assessment, as treatment strategies differ considerably between conditions.
Sources: NHS: Alopecia areata; NHS: Dandruff/seborrhoeic dermatitis; NHS: Psoriasis; NICE CKS: Alopecia areata; BAD patient information: Lichen planopilaris; NHS: Ringworm (tinea) of the scalp.
| Condition | Mechanism of Hair Loss | Key Diagnostic Steps | First-Line NHS Treatment | Scarring? |
|---|---|---|---|---|
| Seborrhoeic dermatitis | Malassezia-driven inflammation; may trigger telogen effluvium in severe cases | Clinical diagnosis; consider patch testing if contact allergen suspected | Ketoconazole 2% shampoo; short-term topical corticosteroid (e.g., betamethasone valerate) | No |
| Scalp psoriasis | Immune-mediated plaques disrupt follicular environment; diffuse shedding if severe | Clinical examination; dermoscopy; biopsy if diagnosis uncertain | Calcipotriol/betamethasone foam; coal tar; salicylic acid; biologics for severe disease (NICE TA) | No |
| Alopecia areata | CD8+ T lymphocytes attack follicle bulb; loss of immune privilege; patchy shedding | Clinical history, pattern assessment; NICE CKS stepwise approach; FBC, ferritin, TFTs | Potent topical corticosteroids; intralesional corticosteroid injections; JAK inhibitors (baricitinib, ritlecitinib) for severe disease | No (regrowth possible) |
| Tinea capitis | Fungal infection causes follicular inflammation, scaling, and hair breakage | Hair pluck/brush technique and scalp scrapings for mycology; Wood's lamp for Microsporum | Oral terbinafine (Trichophyton); oral griseofulvin (Microsporum); adjunctive antifungal shampoo | No |
| Lichen planopilaris | Persistent inflammation destroys follicular stem cell niche in bulge region | Dermoscopy; scalp biopsy for histopathology; specialist referral essential | Specialist-initiated; topical/intralesional corticosteroids; hydroxychloroquine; early treatment critical | Yes (permanent) |
| Telogen effluvium | Systemic stressor (illness, surgery, postpartum, medication) shifts follicles to telogen phase | Clinical history; FBC, ferritin, TFTs to exclude nutritional/systemic cause | Address underlying trigger; correct nutritional deficiencies (iron) if confirmed; reassurance | No |
| Allergic contact dermatitis | Allergen (e.g., PPD in hair dye) triggers inflammatory response; secondary shedding | Patch testing by dermatologist to identify causative allergen | Allergen avoidance; topical corticosteroids for acute inflammation; fragrance-free products | No |
How Scalp Conditions Lead to Hair Thinning and Shedding
Scalp inflammation disrupts the hair follicle cycle, potentially causing telogen effluvium in milder conditions or permanent follicular destruction in scarring alopecias such as lichen planopilaris.
The relationship between scalp inflammation and hair loss is rooted in the biology of the hair follicle. Hair follicles are highly sensitive structures that depend on a stable, well-regulated local environment to cycle through their growth phases — anagen (growth), catagen (transition), and telogen (resting/shedding). When inflammation disrupts this environment, follicular function can be compromised.
In conditions such as seborrhoeic dermatitis and psoriasis, chronic inflammation may alter the scalp microbiome and increase the production of pro-inflammatory cytokines. In some individuals, this may contribute to a premature shift of follicles from the anagen phase into the telogen phase — a process known as telogen effluvium — resulting in diffuse shedding. However, overt hair loss is not a universal feature of psoriasis or seborrhoeic dermatitis, and tends to occur mainly when inflammation or scaling is particularly severe or prolonged.
In alopecia areata, the mechanism is more targeted. CD8+ T lymphocytes infiltrate the hair follicle bulb, disrupting the immune privilege that normally protects follicles from immune attack. This leads to abrupt cessation of hair growth and the characteristic round or oval patches of hair loss. Importantly, in alopecia areata the follicles are not permanently destroyed in most cases, which is why regrowth remains possible.
Scarring alopecias such as lichen planopilaris represent the most severe end of the spectrum. Here, persistent inflammation targets and destroys the follicular stem cell niche in the bulge region, resulting in permanent hair loss. Early recognition and prompt specialist treatment are therefore critical to preserving follicular integrity and preventing long-term damage.
Sources: BAD guideline: Alopecia areata; BAD patient information: Scarring alopecias; NICE CKS: Alopecia areata.
Diagnosing Inflammatory Scalp Conditions in the UK
Diagnosis begins with clinical history and examination; investigations may include blood tests, scalp mycology, and patch testing, with dermoscopy or scalp biopsy used by dermatologists when scarring alopecia is suspected.
Accurate diagnosis of scalp inflammation and hair loss typically begins with a detailed clinical history and physical examination. A GP will usually assess the pattern and duration of hair loss, associated symptoms such as itching, burning, or scaling, and any relevant personal or family history of skin or immune-mediated conditions.
In primary care, the following investigations may be requested, guided by the clinical history and examination findings:
-
Blood tests – including full blood count, ferritin, and thyroid function tests (TFTs) to exclude systemic or nutritional causes; vitamin D testing should be requested only where clinically indicated, not routinely
-
Scalp mycology – where tinea capitis is suspected, the correct approach is hair pluck or brush technique and scalp scrapings sent for microscopy and culture; Wood's lamp examination may assist in identifying Microsporum species, particularly in children; routine swabs are not appropriate for fungal diagnosis
-
Patch testing – performed by a dermatologist to identify contact allergens if allergic contact dermatitis is considered
If the diagnosis remains unclear or a scarring alopecia is suspected, referral to an NHS dermatologist is appropriate. Dermatologists may use dermoscopy — a non-invasive technique using a handheld magnifying device — to examine the scalp surface and follicular openings in detail. This can help differentiate between non-scarring and scarring conditions without the need for biopsy in many cases.
A scalp biopsy may be recommended when dermoscopy findings are inconclusive or when a scarring alopecia such as lichen planopilaris, discoid lupus erythematosus, or folliculitis decalvans is suspected. Histopathological analysis of the biopsy specimen provides definitive information about the pattern and severity of follicular inflammation. NICE CKS topics on alopecia areata, tinea capitis, and psoriasis support a structured, stepwise approach to investigation, ensuring that common and treatable causes are excluded before more invasive procedures are undertaken.
Sources: NICE CKS: Alopecia areata; NICE CKS: Tinea capitis; NICE CKS: Psoriasis; BAD guideline: Primary cicatricial (scarring) alopecias.
Treatment Options Available on the NHS
NHS treatment is diagnosis-led and ranges from antifungal shampoos and topical corticosteroids for seborrhoeic dermatitis and psoriasis, to systemic antifungals for tinea capitis and JAK inhibitors for severe alopecia areata.
Treatment for scalp inflammation and hair loss on the NHS is guided by the underlying diagnosis, and a range of effective options are available across primary and secondary care settings.
For seborrhoeic dermatitis, first-line treatment typically involves medicated shampoos containing ketoconazole 2% (available on prescription and over the counter), selenium sulphide, or antifungal actives such as piroctone olamine. Note that the availability of zinc pyrithione-containing products in the UK has changed following regulatory review, and formulations vary; a pharmacist can advise on currently available options. Topical corticosteroids such as betamethasone valerate scalp application may be prescribed for short-term use to reduce acute inflammation, with review and step-down as recommended in the BNF and product SmPC. Maintenance therapy with antifungal shampoos is often recommended to prevent relapse.
For scalp psoriasis, treatment options include:
-
Topical corticosteroids – often combined with vitamin D analogues (e.g., calcipotriol/betamethasone dipropionate foam); potent topical corticosteroids should be used for the shortest effective duration with clinical review
-
Coal tar preparations – available as shampoos and scalp solutions
-
Salicylic acid – used to soften and lift thick plaques before other treatments are applied
-
Biologic agents – for moderate-to-severe psoriasis unresponsive to topical and conventional systemic therapy, NICE has approved several biologic agents including adalimumab and secukinumab, among others; these are initiated and monitored by specialists in line with NICE Technology Appraisals and local Integrated Care Board (ICB) commissioning pathways
For alopecia areata, potent topical corticosteroids are the mainstay of NHS treatment. Intralesional corticosteroid injections, administered by a dermatologist, can be effective for localised patches. JAK inhibitors represent a significant advance in treatment for severe alopecia areata: baricitinib and ritlecitinib have both received MHRA approval for severe alopecia areata in adults (ritlecitinib is also licensed for patients aged 12 years and over). NHS access is subject to NICE appraisal and local ICB commissioning decisions. These are specialist-initiated therapies requiring safety monitoring for infection risk, venous thromboembolism, and other adverse effects as detailed in the respective SmPCs; patients and clinicians should report suspected adverse reactions via the MHRA Yellow Card scheme.
Experiencing these side effects? Our pharmacists can help you navigate them →
For tinea capitis, systemic antifungal therapy is required, as topical agents alone are insufficient to eradicate scalp fungal infection. Treatment choice should be guided by the likely causative organism: oral terbinafine is generally preferred for Trichophyton species, whilst griseofulvin is often used for Microsporum species, particularly in children. Adjunctive antifungal shampoo (e.g., ketoconazole or selenium sulphide) is recommended to reduce transmission. Household contacts should be screened, and public health advice regarding school attendance should follow local guidance (see 'When to See a GP or Dermatologist' below).
Sources: BNF: Topical corticosteroids; seborrhoeic dermatitis treatments; SmPC (EMC): Ketoconazole 2% shampoo; betamethasone valerate scalp application; terbinafine tablets; griseofulvin; MHRA/EMC SmPC: Baricitinib; ritlecitinib; NICE Technology Appraisals: Biologics for psoriasis; NICE CKS: Tinea capitis; BAD guideline: Alopecia areata.
Managing Scalp Health and Supporting Hair Regrowth
Gentle hair care, a balanced diet with adequate iron and zinc, and stress management can complement prescribed treatments, though lifestyle measures alone are unlikely to resolve inflammatory scalp conditions.
Alongside prescribed treatments, a number of evidence-informed self-care strategies can support scalp health and create a more favourable environment for hair regrowth. It is important to note that lifestyle measures alone are unlikely to resolve inflammatory scalp conditions, but they can meaningfully complement medical treatment.
Gentle hair care practices are particularly important:
-
Use mild, fragrance-free shampoos if the scalp is sensitive or reactive
-
Avoid excessive heat styling, tight hairstyles (which can cause traction-related hair loss), and chemical treatments that can exacerbate scalp irritation
-
For those with scarring alopecia, protecting the scalp from sun exposure is also advisable
-
Wash hair regularly but not excessively — for seborrhoeic dermatitis, frequent washing with medicated shampoo is often beneficial
Nutritional support plays a supporting role. Ensuring adequate intake of iron and zinc through a balanced diet may help reduce shedding associated with nutritional deficiency. Supplementation should only be considered where deficiency has been confirmed by blood tests and discussed with a healthcare professional. Routine biotin (vitamin B7) supplementation is not recommended in the absence of confirmed deficiency; the MHRA has issued a safety communication noting that high-dose biotin can interfere with a range of laboratory tests, including thyroid function and troponin assays, potentially leading to inaccurate results.
Stress management is also relevant, as psychological stress is a recognised trigger for telogen effluvium and may worsen immune-mediated conditions such as alopecia areata. Techniques such as mindfulness, regular physical activity, and adequate sleep can support overall wellbeing and may indirectly benefit scalp health.
For those experiencing significant hair loss, referral to a dermatology or specialist hair clinic may be appropriate. Trichologists — practitioners who specialise in hair and scalp health — are not statutorily regulated health professionals and are generally outside NHS care pathways; if you are considering consulting one privately, ensure they hold recognised professional qualifications. Wigs and hairpieces are available on the NHS for certain conditions, including alopecia areata, subject to local ICB policies; prescription charges or exemptions may apply depending on individual circumstances.
Sources: MHRA Drug Safety Update: Biotin (vitamin B7) interference with laboratory tests; NHS: Hair loss; BAD patient information: Scarring alopecias; NHS: Wigs and fabric supports.
When to See a GP or Dermatologist
See a GP if scalp redness, itching, or hair loss persists beyond four to six weeks, worsens rapidly, or is accompanied by pustules, scarring, or systemic symptoms; suspected scarring alopecia warrants urgent dermatology referral.
Many people experience mild, transient scalp irritation or temporary hair shedding that resolves without medical intervention. However, certain signs and symptoms warrant prompt assessment by a GP or specialist to prevent progression and preserve hair follicle health.
You should contact your GP if you notice:
-
Persistent or worsening scalp redness, itching, or scaling that does not respond to over-the-counter treatments after four to six weeks
-
Sudden or rapidly progressing hair loss, particularly if occurring in patches
-
Hair loss accompanied by systemic symptoms such as fatigue, joint pain, or skin changes elsewhere on the body, which may suggest an underlying immune-mediated condition
-
Scalp tenderness, pustules, or crusting, which may indicate infection requiring antibiotic or antifungal treatment
-
Any area of the scalp where hair loss appears permanent, with visible scarring or loss of follicular openings
Urgent or early dermatology referral is particularly important in the following situations:
-
Suspected scarring alopecia (e.g., lichen planopilaris, discoid lupus erythematosus, folliculitis decalvans), where irreversible follicular damage can occur rapidly without treatment
-
A kerion — a boggy, tender, inflammatory mass on the scalp — which is a severe form of tinea capitis requiring prompt systemic antifungal treatment
-
Rapidly progressive or painful scalp inflammation with pustules or crusting
-
Patients who are immunosuppressed, in whom infections may behave atypically
Children presenting with scaly, inflamed scalp patches and hair loss should be assessed promptly to exclude tinea capitis. Once systemic antifungal treatment has been started, school exclusion is not usually required; however, hair items (combs, hats, pillowcases) should not be shared, adjunctive antifungal shampoo should be used, and household contacts should be screened. Local public health guidance should be followed.
It is worth remembering that scalp inflammation and hair loss can have a significant psychological impact. If hair loss is affecting your mental health or daily functioning, do not hesitate to raise this with your GP, who can signpost you to appropriate support services. Early intervention — both medical and psychological — consistently leads to better outcomes, and there is no need to manage these conditions alone.
Sources: NICE CKS: Alopecia areata; NICE CKS: Tinea capitis; UKHSA guidance: Infection control in schools (ringworm/tinea); BAD guideline: Primary cicatricial alopecias.
Frequently Asked Questions
Can scalp inflammation cause permanent hair loss?
Scalp inflammation can cause permanent hair loss if it leads to a scarring (cicatricial) alopecia, such as lichen planopilaris or discoid lupus erythematosus, which destroys the follicular stem cells. In non-scarring conditions like seborrhoeic dermatitis or alopecia areata, hair follicles are generally preserved and regrowth is possible with appropriate treatment.
What is the difference between scalp psoriasis and seborrhoeic dermatitis?
Scalp psoriasis produces thick, well-defined silvery-white plaques and is driven by an immune-mediated inflammatory process, whereas seborrhoeic dermatitis causes greasy, yellowish flaking linked to Malassezia yeast overgrowth. Both can cause itching and contribute to hair shedding, but they require different treatments, so accurate diagnosis by a GP or dermatologist is important.
Is hair loss from scalp inflammation reversible?
In most non-scarring inflammatory conditions — including alopecia areata, seborrhoeic dermatitis, and tinea capitis — hair loss is reversible once the underlying condition is effectively treated. Scarring alopecias are the exception, as follicular destruction is permanent, which is why early diagnosis and treatment are critical.
Can I use a steroid shampoo or scalp treatment without a prescription?
Some mild antifungal shampoos, such as ketoconazole 1%, are available over the counter in the UK, but potent topical corticosteroid scalp applications require a prescription. Using prescription-strength steroids without medical supervision carries risks including skin thinning, so it is advisable to see a GP for an accurate diagnosis before starting treatment.
How do I get a referral to a dermatologist for scalp inflammation and hair loss on the NHS?
You can request a referral to an NHS dermatologist through your GP, who will assess whether specialist input is needed based on your symptoms, examination findings, and response to initial treatment. Referral is particularly recommended if a scarring alopecia is suspected, if hair loss is rapidly progressing, or if the diagnosis remains unclear after initial investigations.
Can stress make scalp inflammation and hair loss worse?
Yes, psychological stress is a recognised trigger for telogen effluvium — a form of diffuse hair shedding — and can also worsen immune-mediated conditions such as alopecia areata. Managing stress through regular physical activity, adequate sleep, and mindfulness techniques may help reduce flare-ups, though medical treatment of the underlying condition remains the priority.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
